274 P.H. Reggio
Adams IB, Ryan W, Singer M, Razdan RK, Compton DR, Martin BR (1995a) Pharmacological
and behavioral evaluation of alkylated anandamide analogs. Life Sci 56:2041–2048
Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, Martin BR (1995b) Eval-
uation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
J Pharmacol Exp Ther 273:1172–1181
Barnett-Norris J, Guarnieri F, Hurst DP, Reggio PH (1998) Exploration of biologically rel-
evant conformations of anandamide, 2-arachidonylglycerol, and their analogues using
conformational memories. J Med Chem 41:4861–4872
Barnett-Norris J, Hurst DP, Buehner K, Ballesteros JA, Guarnieri F, Reggio PH (2002a)
Agonist alkyl tail interaction with cannabinoid CB1 receptor V6.43/I646 groove induces
a helix 6 active conformation. Int J Quantum Chem 88:76–86
Barnett-Norris J, Hurst DP, Lynch DL, Guarnieri F, Makriyannis A, Reggio PH (2002b)
Conformational memories and the endocannabinoid binding site at the cannabinoid
CB1 receptor. J Med Chem 45:3649–3659
Berglund BA, Boring DL, Wilken GH, Makriyannis A, Howlett AC, Lin S (1998) Structural
requirements for arachidonylethanolamide interaction with CB1 and CB2 cannabinoid
receptors: pharmacology of the carbonyl and ethanolamide groups. Prostaglandins
Leukot Essent Fatty Acids 59:111–118
Berglund BA, Boring DL, Howlett AC (1999) Investigation of structural analogs of prosta-
glandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in
rat brain and human tonsils. Adv Exp Med Biol 469:527–533
Berglund BA, Fleming PR, Rice KC, Shim JY, Welsh WJ, Howlett AC (2000) Development
of a novel class of monocyclic and bicyclic alkyl amides that exhibit CB1 and CB2
cannabinoid receptor affinity and receptor activation. Drug Des Discov 16:281–294
Bonechi C, Brizzi A, Brizzi V, Francoli M, Donati A, Rossi C (2001) Conformational analysis
of N-arachidonylethanolamide (anandamide) using nuclear magnetic R\resonanceand
theoretical calculations. Magn Reson Chem 39:432–437
Bouaboula M, Perrachon S, Milligan L, Canat X, Rinaldi-Carmona M, Portier M, Barth F,
Calandra B, Pecceu F, Lupker J, Maffrand JP, Le Fur G, Casellas P (1997) A selective
inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein
kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for
a new model of receptor/ligand interactions. J Biol Chem 272:22330–22339
Bouaboula M, Desnoyer N, Carayon P, Combes T, Casellas P (1999) Gi protein modulation
induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2:
implication for intracellular signalization cross-regulation. Mol Pharmacol 55:473–480
Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF (2002) Structural adaptations
in a membrane enzyme that terminates endocannabinoid signaling. Science 298:1793–
1796
Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled
cannabinoid receptor in mouse brain. Mol Pharmacol 60:155–163
Busch-Petersen J, Hill WA, Fan P, Khanolkar A, Xie XQ, Tius MA, Makriyannis A (1996)
Unsaturated side chain beta-11-hydroxyhexahydrocannabinol analogs. J Med Chem
39:3790–3796
ChinC,Lucas-LenardJ,AbadjiV,KendallDA(1998)Ligandbindingandmodulationofcyclic
AMP levels depend on the chemical nature of residue 192 of the human cannabinoid
receptor 1. J Neurochem 70:366–373
Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR (1992) Aminoalkylindole analogs:
cannabimimetic activity of a class of compounds structurally distinct from delta-9-
tetrahydrocannabinol. J Pharmacol Exp Ther 263:1118–1126
Corey EJ, Niwa H, Falck JR (1979) Selective epoxidation of ecosa-cis-5, 8, 11, 14-tetraenoic
(arachidonic) acid and eicosa-cis-8, 11,14-trienoic acid. J Am Chem Soc 101:1586–1587
D’Ambra TE, Estep KG, Bell MR, Eissenstat MA, Josef KA, Ward SJ, Haycock DA, Baizman
ER, Casiano FM, Beglin NC, et al (1992) Conformationally restrained analogues of
pravadoline: nanomolar potent, enantioselective, (aminoalkyl)indole agonists of the
cannabinoid receptor. J Med Chem 35:124–135